System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Wilfried Eberhardt is an expert in Oncology at Essen University Hospital (Germany). As of October 2026, ScienceLeadR ranks Wilfried Eberhardt in the top 1% of experts worldwide for Bronchial Neoplasms, Thoracic Neoplasms and Lung Neoplasms. Wilfried Eberhardt has authored 417 publications, the most recent in 2026, and is an investigator in 16 clinical trials. SLR score: 1,397 (community average: 125). How the SLR is computed.

LeadR Profile

Wilfried Eberhardt Essen University Hospital Germany
1 397 ScienceLeadR Reputation 1397

Unlock

Register Login
Network Map

Oncology

Subspecialties: Pulmonology - Nuclear Medicine - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026
Source: PubMed

Essen University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 417

Citations

Citations: 33 123 1st author: 55 Last author: 54 Unique author: 14

Main journals

J Thorac Oncol 70
J Clin Oncol 46
Ann Oncol 37
Lung Cancer 30
Pneumologie 26

Best Journals

Ann Oncol 8
Lancet Oncol 7
J Clin Oncol 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Subclinical pulmonary embolism in first-line/induction therapy of lung cancer - a remaining clinically relevant adverse event.
PMID 42835926 — cells, lung, embolism, incidence, neoplasms, carcinoma, non-small-cell lung, drug therapy, drug-related side effects and adverse reactions, lung neoplasms, pulmonary embolism, therapeutics, chemotherapy		Front Oncol20260
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315).
PMID 42512379 — registries, cells, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, chemoradiotherapy, small cell lung carcinoma, therapeutics		Cancers (Basel)20260
Real-World Emulation of Landmark Lung Cancer Trials: A Registry-Based Reconstruction of KN189, KN407, IMpower133, and PACIFIC.
PMID 42279336 — registries, lung, neoplasms, lung neoplasms, therapeutics		Cancers (Basel)20260
Treatment Patterns, Outcome, and Quality of Life of Patients With Extensive-Stage SCLC Receiving Third-Line Therapy-Data From the German CRISP Registry (AIO-TRK-0315): A Brief Report.
PMID 41969361 — registries, quality of life, confidence intervals, neoplasms, drug therapy, therapeutics, topotecan, chemotherapy		JTO Clin Res Rep20260
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315).
PMID 41872110 — registries, oncogenes, cells, lung, incidence, brain, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, neoplasm metastasis, small cell lung carcinoma, risk factors		Int J Cancer20260

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 3 9
Phase 2 4
N/A 2
Phase 4 1

By status:

Completed 12
Recruiting 2
Terminated 1
Unknown 1

By type:

Interventional 14
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 2
multicentricup10 11

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS